Recent publications published by researchers at the MRC WIMM.
Post-acute COVID-19 neuropsychiatric symptoms are not associated with ongoing nervous system injury.
Journal article
Taquet M. et al, (2024), Brain Commun, 6
Cohort Profile: Post-Hospitalisation COVID-19 (PHOSP-COVID) study
Journal article
(2023), International journal of epidemiology, 53
Single cell spatial analysis reveals inflammatory foci of immature neutrophil and CD8 T cells in COVID-19 lungs.
Journal article
Weeratunga P. et al, (2023), Nat Commun, 14
Long COVID research: an update from the PHOSP-COVID Scientific Summit.
Journal article
Brightling CE. et al, (2023), Lancet Respir Med, 11, e93 - e94
Multiorgan MRI findings after hospitalisation with COVID-19 in the UK (C-MORE): a prospective, multicentre, observational cohort study.
Journal article
C-MORE/PHOSP-COVID Collaborative Group None., (2023), Lancet Respir Med, 11, 1003 - 1019
Acute blood biomarker profiles predict cognitive deficits 6 and 12 months after COVID-19 hospitalization.
Journal article
Taquet M. et al, (2023), Nat Med, 29, 2498 - 2508
Implementable Deep Learning for Multi-sequence Proton MRI Lung Segmentation: A Multi-center, Multi-vendor, and Multi-disease Study.
Journal article
Astley JR. et al, (2023), J Magn Reson Imaging, 58, 1030 - 1044
Neutrophil levels correlate with quantitative extent and progression of fibrosis in IPF: results of a single-centre cohort study.
Journal article
Achaiah A. et al, (2023), BMJ Open Respir Res, 10
A randomised phase 2a study to investigate the effects of blocking interleukin-33 with tozorakimab in patients hospitalised with COVID-19: ACCORD-2.
Journal article
Wilkinson T. et al, (2023), ERJ Open Res, 9
Effects of sleep disturbance on dyspnoea and impaired lung function following hospital admission due to COVID-19 in the UK: a prospective multicentre cohort study.
Journal article
Jackson C. et al, (2023), Lancet Respir Med, 11, 673 - 684
Prevalence of swallow, communication, voice and cognitive compromise following hospitalisation for COVID-19: the PHOSP-COVID analysis.
Journal article
Dawson C. et al, (2023), BMJ Open Respir Res, 10
Determinants of recovery from post-COVID-19 dyspnoea: analysis of UK prospective cohorts of hospitalised COVID-19 patients and community-based controls.
Journal article
Zheng B. et al, (2023), Lancet Reg Health Eur, 29
Residual Lung Abnormalities after COVID-19 Hospitalization: Interim Analysis of the UKILD Post-COVID-19 Study.
Journal article
Stewart I. et al, (2023), Am J Respir Crit Care Med, 207, 693 - 703
Prevalence of physical frailty, including risk factors, up to 1 year after hospitalisation for COVID-19 in the UK: a multicentre, longitudinal cohort study.
Journal article
McAuley HJC. et al, (2023), EClinicalMedicine, 57
Correction: The effect of COVID rehabilitation for ongoing symptoms Post HOSPitalisation with COVID-19 (PHOSP-R): protocol for a randomised parallel group controlled trial on behalf of the PHOSP consortium.
Journal article
Daynes E. et al, (2023), Trials, 24
Molnupiravir versus placebo in unvaccinated and vaccinated patients with early SARS-CoV-2 infection in the UK (AGILE CST-2): a randomised, placebo-controlled, double-blind, phase 2 trial.
Journal article
Khoo SH. et al, (2023), Lancet Infect Dis, 23, 183 - 195
The effect of COVID rehabilitation for ongoing symptoms Post HOSPitalisation with COVID-19 (PHOSP-R): protocol for a randomised parallel group controlled trial on behalf of the PHOSP consortium.
Journal article
Daynes E. et al, (2023), Trials, 24
Spatial transcriptomic characterization of COVID-19 pneumonitis identifies immune circuits related to tissue injury.
Journal article
Cross AR. et al, (2023), JCI Insight, 8
Characteristics and risk factors for post-COVID-19 breathlessness after hospitalisation for COVID-19.
Journal article
Daines L. et al, (2023), ERJ Open Res, 9